Navigation Links
Mayuka Labs R&D Centre Gets DSIR Recognition
Date:1/12/2009

NEW DELHI, India, January 12 /PRNewswire/ -- New Delhi based Mayuka Labs Private Limited has received recognition for its in-house research & development facility from the department of scientific and industrial research (DSIR) under the ministry of science and technology, Government of India.

With twenty-one scientists working round the clock at its R&D and Pilot unit at Nacharam, Mayuka Labs has crossed this milestone in its first year of operations. The company has filed two international PCT patents in 2008 and is working on new process technologies on 12 different molecules. The companies customer base ranges from big pharma clients like Boehringer Ingelheim to leading generic companies like Mylan subsidiary Matrix Labs, Dr. Reddy's and Unimark Remedies.

"We create value for our customers through innovative new processes. As Thomas Friedman put it, this is a flat and deeply interconnected world and our R&D teams work 24/7 to cater to customers across the world. The DSIR recognition for our R&D, is a key milestone as we continue to drive efficiencies in the Custom Research, Custom Synthesis and Custom Manufacturing space," said Dr.Chandra Sekhar N K, Chairman and Managing Director, Mayuka Labs.

With this accreditation, Mayuka Labs is entitled to receive support from government establishments such as Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT) and the Department of Science and Technology (DST) for its projects.

According to the DSIR website there are only one thousand two hundred and forty seven companies across all industries, including research labs set up by multi-national companies which are recognized by DSIR in India. Within the pharma and biotech space, there are less than two hundred. Mayuka Labs is now a part of this select group.

The Government recognition of its R&D center, apart from recognizing the innovative work being done by Mayuka scientists enables the company to enjoy a weighted tax deduction of 150% on its R&D expenses, along with complete exemption of duties on import of materials, equipment and machinery for R&D purposes.

About Mayuka Labs

New Delhi based Mayuka Labs was established in July, 2007 and set up its Research Labs in October 2007. The company is funded by US investors and offers Custom Research, Custom Synthesis and Custom Manufacturing services to innovator and generic companies across the world. Its R&D and pilot plant is in Nacharam Hyderabad and its API facility is located in Kopargaon, Maharashtra.

    Contact :

    Dr.Chandra Sekhar N K
    Chairman and Managing Director,
    Mayuka Labs Private Limited
    chandra@mayukalabs.com
    +91(0)11-46523601



'/>"/>
SOURCE Mayuka Labs Private Limited
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE
2. New nanotechnology centre helps turn big ideas into real products
3. VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics
4. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
5. New funding to charge energy research at UCL and the London Centre for Nanotechnology
6. European Centre for Modern Drug Discovery Established in Hamburg
7. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
8. Consistency, Flexibility Key in Improving Rewards & Recognition Programs
9. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
10. Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing
11. Synthetech Earns National Recognition for Performance Improvement Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):